Winton Group’s RxSight RXST Stock Holding History

Winton Group’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,362	Closed	-$76.2K	–	1452
2026 Q1	$76.2K	Sell	12,362 -3,091	-20%	-$25.7K	﹤0.01%	1053
2025 Q4	$161K	Buy	+15,453	New	+$155K	0.01%	848
2025 Q3	–	Sell	-11,873	Closed	-$154K	–	993
2025 Q2	$154K	Buy	+11,873	New	+$179K	0.01%	762

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Winton Group's RXST Position: Q2 2026 in Review

Winton Group sold out of RxSight (RXST) in Q2 2026, closing a stake of 12,362 shares — an estimated $76.2K sold.

Winton Group first reported a position in RXST in Q2 2025 and held it in 3 quarters. The position peaked at $161K in Q4 2025. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Winton Group reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
Winton Group sold 12,362 RxSight shares in Q2 2026, an estimated $76.2K.
Winton Group first reported a position in RxSight in Q2 2025 and held it in 3 quarters.
Winton Group's RxSight position peaked at $161K in Q4 2025.
151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.